🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
This study will assess the efficacy of daratumumab in combination with ixaz...
Status
Unknown
Location
General Hospital of Athens "Alexandra"
Start Date
2018-12
Trial ID
NCT03746652
Treatments Being Tested
Adult patients with a confirmed diagnosis of symptomatic and relapsed and/o...
Status
Active Not Recruiting
Location
Emek Medical Center
Start Date
2021-03-25
Trial ID
NCT04790474
Treatments Being Tested
Allogeneic stem cell (allo SCT) transplantation for multiple myeloma is a p...
Status
Terminated
Location
University Hospital of Freiburg
Start Date
2023-03-03
Trial ID
NCT05675319
Treatments Being Tested
This phase I trial studies the side effects and best dose of daratumumab, i...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-02-07
Trial ID
NCT03283917
Treatments Being Tested
A randomized Phase II clinical trial will be conducted to assess the impact...
Status
Active Not Recruiting
Location
Northern Light Eastern Maine Medical Center
Start Date
2020-10-21
Trial ID
NCT04009109
Treatments Being Tested
The MyDRUG study is a type of Precision Medicine trial to treat patients wi...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2019-04-01
Trial ID
NCT03732703
Treatments Being Tested
This protocol is a phase II multicenter, randomized, open label study desig...
Status
Active Not Recruiting
Location
Hradec Kralove-University Hospital Hradec Kralove
Start Date
2019-04-16
Trial ID
NCT03896737
Treatments Being Tested
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597
This phase II trial studies how well daratumumab, bortezomib, and dexametha...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-01-17
Trial ID
NCT03763162
Treatments Being Tested